marginally non-significantp = 0.08
EUS ablation with ethanol demonstrated the highest risk of adverse events (16%; 95%CI: 13–20; I 2 : 91.0%), with marginally non-significant difference from RFA (7%; 95%CI: 0–12; I 2 = 0%; p = 0.08).
EUS ablation with ethanol demonstrated the highest risk of adverse events (16%; 95%CI: 13–20; I 2 : 91.0%), with marginally non-significant difference from RFA (7%; 95%CI: 0–12; I 2 = 0%; p = 0.08).